In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

EyeMedics, LLC

Latest From EyeMedics, LLC

Deals Shaping the Medical Industry, January 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2016.

Deals BioPharmaceutical

Lilly's E-Venture Fund: Getting In At The Bottom

With investors still generally staying out of e-health, a couple of Big Pharma companies think it's time to get in. First, Merck & Co. Inc. announced last November that former Merck-Medco chairman, Per Lofberg would head a $100 million fund dedicated to Internet Health care. And now, Eli Lilly & Co. has just launched the $50 million e.Lilly Venture Fund. Lilly's fund, which will focus on companies with technologies that the company can use, rather than return on investment, will make investments of up to $3 million in 12 to 15 companies over the next year or so.

Business Strategies Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals